Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

1.

Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.

Landis MN, Davis CL, Bellus GA, Wolverton SE.

J Am Acad Dermatol. 2011 Nov;65(5):1054-1058.e1. doi: 10.1016/j.jaad.2010.08.003. Epub 2011 May 6.

PMID:
21550136
[PubMed - indexed for MEDLINE]
2.

Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.

Archer-Dubon C, Alvarez-Zavala B, Reyes E, Orozco-Topete R.

Dermatol Online J. 2008 Dec 15;14(12):1.

PMID:
19265614
[PubMed - indexed for MEDLINE]
Free Article
3.

Muir-Torre Syndrome: expanding the genotype and phenotype--a further family with a MSH6 mutation.

Murphy HR, Armstrong R, Cairns D, Greenhalgh KL.

Fam Cancer. 2008;7(3):255-7. doi: 10.1007/s10689-008-9183-y. Epub 2008 Jan 31.

PMID:
18236172
[PubMed - indexed for MEDLINE]
4.

Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.

Ponti G, Losi L, Pedroni M, Lucci-Cordisco E, Di Gregorio C, Pellacani G, Seidenari S.

J Invest Dermatol. 2006 Oct;126(10):2302-7. Epub 2006 Jul 6.

PMID:
16826164
[PubMed - indexed for MEDLINE]
Free Article
5.

Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombination.

Yanaba K, Nakagawa H, Takeda Y, Koyama N, Sugano K.

Br J Dermatol. 2008 Jan;158(1):150-6. Epub 2007 Oct 17.

PMID:
17941949
[PubMed - indexed for MEDLINE]
6.

Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.

Mathiak M, Rütten A, Mangold E, Fischer HP, Ruzicka T, Friedl W, Propping P, Kruse R.

Am J Surg Pathol. 2002 Mar;26(3):338-43.

PMID:
11859205
[PubMed - indexed for MEDLINE]
7.

Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma.

Kleinerman R, Marino J, Loucas E.

Dermatol Online J. 2012 May 15;18(5):3.

PMID:
22630573
[PubMed - indexed for MEDLINE]
Free Article
8.

Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme.

Park DM, Yeaney GA, Hamilton RL, Mabold J, Urban N, Appleman L, Flickinger J, Lieberman F, Mintz A.

Neuro Oncol. 2009 Aug;11(4):452-5. doi: 10.1215/15228517-2008-101. Epub 2008 Nov 21.

PMID:
19028998
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

[Female patient with Muir-Torre syndrome].

Negraszus N, Jöhrens K, Bertelmann E.

Ophthalmologe. 2010 Nov;107(11):1059-62. doi: 10.1007/s00347-010-2165-0. German.

PMID:
20393721
[PubMed - indexed for MEDLINE]
10.

Glioblastoma multiforme in the Muir-Torre syndrome.

Binder ZA, Johnson MW, Joshi A, Hann CL, Griffin CA, Olivi A, Riggins GJ, Gallia GL.

Clin Neurol Neurosurg. 2011 Jun;113(5):411-5. doi: 10.1016/j.clineuro.2010.12.011. Epub 2011 Feb 1.

PMID:
21288634
[PubMed - indexed for MEDLINE]
11.

Muir-Torre syndrome.

Navi D, Wadhera A, Fung MA, Fazel N.

Dermatol Online J. 2006 Sep 8;12(5):4.

PMID:
16962019
[PubMed - indexed for MEDLINE]
12.

Muir-Torre syndrome.

Lachiewicz AM, Wilkinson TM, Groben P, Ollila DW, Thomas NE.

Am J Clin Dermatol. 2007;8(5):315-9.

PMID:
17902735
[PubMed - indexed for MEDLINE]
13.

Muir-Torre syndrome: role of the dermatopathologist in diagnosis.

Curry ML, Eng W, Lund K, Paek D, Cockerell CJ.

Am J Dermatopathol. 2004 Jun;26(3):217-21.

PMID:
15166510
[PubMed - indexed for MEDLINE]
14.

An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.

Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV, Dove-Edwin I, Cerio R, McGregor JM.

J Invest Dermatol. 2001 Feb;116(2):246-53.

PMID:
11180000
[PubMed - indexed for MEDLINE]
Free Article
15.

An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation.

Arnold A, Payne S, Fisher S, Fricker D, Soloway J, White SM, Novelli M, MacDonald K, Mackay J, Groves R, Canham N.

Fam Cancer. 2007;6(3):317-21. Epub 2007 Feb 24.

PMID:
17323113
[PubMed - indexed for MEDLINE]
16.

Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer.

Cesinaro AM, Ubiali A, Sighinolfi P, Trentini GP, Gentili F, Facchetti F.

Am J Dermatopathol. 2007 Aug;29(4):351-8.

PMID:
17667167
[PubMed - indexed for MEDLINE]
17.

[Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].

Kacerovská D, Kazakov DV, Cerná K, Hadravský L, Michal M Jr, Dostál J, Skálová A Jr, Michal M.

Cesk Patol. 2010 Oct;46(4):86-94. Review. Czech.

PMID:
21313735
[PubMed - indexed for MEDLINE]
18.

A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.

Vernez M, Hutter P, Monnerat C, Halkic N, Gugerli O, Bouzourene H.

Fam Cancer. 2007;6(1):141-5.

PMID:
17051350
[PubMed - indexed for MEDLINE]
19.

Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.

Abbas O, Mahalingam M.

J Cutan Pathol. 2009 Jun;36(6):613-9. doi: 10.1111/j.1600-0560.2009.01248.x. Review.

PMID:
19515040
[PubMed - indexed for MEDLINE]
20.

[Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].

Mercader P, García-Melgares ML, Roche E, Sánchez-Carazo JL, Alegre-de Miquel V.

Actas Dermosifiliogr. 2008 Sep;99(7):532-9. Spanish.

PMID:
18682166
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk